Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

80.24
Delayed Data
As of 3:59pm ET
 +0.29 / +0.36%
Today’s Change
63.76
Today|||52-Week Range
86.27
+12.05%
Year-to-Date
Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks
4:03pm / Zacks.com - Paid Partner Content
Let's Talk About CAR-T
Oct 16 / GuruFocus News - Paid Partner Content
American Research & Management Co. Buys DowDuPont Inc, Wells Fargo, US Bancorp, Sells...
2:39pm / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: NIKE, Cisco Systems, Gilead Sciences, Las Vegas Sa...
Oct 16 / Zacks.com - Paid Partner Content
Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen
10:19am / Zacks.com - Paid Partner Content
Top Stock Reports for NIKE, Cisco Systems & Gilead Sciences
Oct 13 / Zacks.com - Paid Partner Content
Let's Talk About CAR-T
Oct 16 / GuruFocus News - Paid Partner Content
Exane Asset Management Buys AT&T Inc, Verizon Communications Inc, CNH Industrial NV, ...
Oct 13 / GuruFocus News - Paid Partner Content
Pharma Industry Outlook - October 2017
Oct 16 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY), TARGET Extend Partnership for NASH Study
Oct 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close79.95
Today’s open80.00
Day’s range79.56 - 80.71
Volume7,041,400
Average volume (3 months)9,504,035
Market cap$104.4B
Dividend yield2.59%
Data as of 3:59pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-24.23%
Earnings growth (next 5 years)-6.45%
Revenue growth (last year)-5.37%
P/E ratio8.7
Price/Sales3.21
Price/Book5.55

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+4.29+2.36%
BIIBBiogen+8.79+2.62%
ILMNIllumina Inc+0.25+0.12%
----
Data as of 3:59pm ET, 10/17/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$2.12
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts